149 related articles for article (PubMed ID: 32213285)
21. A Chronic Lymphocytic Leukemia Patient with Progressive Multifocal Leukoencephalopathy Caused by John Cunningham Virus.
Ramadhani P; Bramantono B; Sedana MP
Acta Med Indones; 2018 Apr; 50(2):151-158. PubMed ID: 29950535
[TBL] [Abstract][Full Text] [Related]
22. Ibrutinib, lenalidomide, and rituximab in relapsed or refractory mantle cell lymphoma (PHILEMON): a multicentre, open-label, single-arm, phase 2 trial.
Jerkeman M; Eskelund CW; Hutchings M; Räty R; Wader KF; Laurell A; Toldbod H; Pedersen LB; Niemann CU; Dahl C; Kuitunen H; Geisler CH; Grønbæk K; Kolstad A
Lancet Haematol; 2018 Mar; 5(3):e109-e116. PubMed ID: 29396091
[TBL] [Abstract][Full Text] [Related]
23. Late onset progressive multifocal leukoencephalopathy in Hodgkin lymphoma.
Aamodt WW; Siegler JE; Viaene AN; Rubenstein MN
J Clin Neurosci; 2017 Sep; 43():132-134. PubMed ID: 28526178
[TBL] [Abstract][Full Text] [Related]
24. [Ibrutinib: A new drug of B-cell malignancies].
Thieblemont C
Bull Cancer; 2015 Jun; 102(6 Suppl 1):S85-90. PubMed ID: 26118882
[TBL] [Abstract][Full Text] [Related]
25. Successful treatment of progressive multifocal leukoencephalopathy with recombinant interleukin-7 and maraviroc in a patient with idiopathic CD4 lymphocytopenia.
Harel A; Horng S; Gustafson T; Ramineni A; Farber RS; Fabian M
J Neurovirol; 2018 Oct; 24(5):652-655. PubMed ID: 29987583
[TBL] [Abstract][Full Text] [Related]
26. Unusual Case of Progressive Multifocal Leukoencephalopathy in a Patient With Sjögren Syndrome.
Onwubiko IN; Taneja K; Gupta N; Mukherjee A
Am J Forensic Med Pathol; 2021 Jun; 42(2):186-190. PubMed ID: 33464755
[TBL] [Abstract][Full Text] [Related]
27. Progressive multifocal leukoencephalopathy: report of three cases in HIV-negative hematological patients and review of literature.
Pelosini M; Focosi D; Rita F; Galimberti S; Caracciolo F; Benedetti E; Papineschi F; Petrini M
Ann Hematol; 2008 May; 87(5):405-12. PubMed ID: 18064459
[TBL] [Abstract][Full Text] [Related]
28. Staphylococcus aureus meningitis in a patient with mantle cell lymphoma under treatment with ibrutinib.
Diamantopoulos PT; Psichogiou M; Pantazatou A; Zervakis K; Rougala N; Giannakopoulou N; Daikos G; Viniou NA
Ann Hematol; 2017 Jun; 96(6):1049-1050. PubMed ID: 28247056
[No Abstract] [Full Text] [Related]
29. Four-year follow-up of a single arm, phase II clinical trial of ibrutinib with rituximab (IR) in patients with relapsed/refractory mantle cell lymphoma (MCL).
Jain P; Romaguera J; Srour SA; Lee HJ; Hagemeister F; Westin J; Fayad L; Samaniego F; Badillo M; Zhang L; Nastoupil L; Kanagal-Shamanna R; Fowler N; Wang ML
Br J Haematol; 2018 Aug; 182(3):404-411. PubMed ID: 29785709
[TBL] [Abstract][Full Text] [Related]
30. Progressive multifocal leukoencephalopathy (PML) in a patient with lymphoma treated with rituximab: A case report and literature review.
Al-Tawfiq JA; Banda RW; Daabil RA; Dawamneh MF
J Infect Public Health; 2015; 8(5):493-7. PubMed ID: 25666327
[TBL] [Abstract][Full Text] [Related]
31. Hyperleukocytosis increases risk of fatal hyperkalemia with new ibrutinib/venetoclax regimen for refractory mantle cell lymphoma.
Verma A; Mbughuni M; Mariash E; Mesa H
J Chemother; 2019; 31(7-8):428-431. PubMed ID: 31738653
[No Abstract] [Full Text] [Related]
32. Posterior Fossa Progressive Multifocal Leukoencephalopathy Secondary to Rituximab.
Guduru M; Bendi VS; Bebawy MS; Bande D; Matta A
Cureus; 2020 Oct; 12(10):e10888. PubMed ID: 33178540
[TBL] [Abstract][Full Text] [Related]
33. Ibrutinib: a review of its use in patients with mantle cell lymphoma or chronic lymphocytic leukaemia.
Kim ES; Dhillon S
Drugs; 2015 May; 75(7):769-76. PubMed ID: 25802231
[TBL] [Abstract][Full Text] [Related]
34. A phase I study of carfilzomib in combination with ibrutinib for relapsed refractory mantle cell lymphoma.
Lee HJ; Schmelz JL; Cramer F; Romaguera JE; Badillo M; Wang M
Br J Haematol; 2020 Mar; 188(6):e94-e98. PubMed ID: 32057090
[No Abstract] [Full Text] [Related]
35. Activity of ibrutinib in mantle cell lymphoma patients with central nervous system relapse.
Bernard S; Goldwirt L; Amorim S; Brice P; Brière J; de Kerviler E; Mourah S; Sauvageon H; Thieblemont C
Blood; 2015 Oct; 126(14):1695-8. PubMed ID: 26239089
[TBL] [Abstract][Full Text] [Related]
36. Probable progressive multifocal leukoencephalopathy-immune reconstitution inflammatory syndrome with immunosuppressant dose reduction following lung transplantation: a case report and literature review.
Ishii K; Yamamoto F; Homma S; Okada Y; Nakamichi K; Saijo M; Tamaoka A
BMC Neurol; 2019 Oct; 19(1):263. PubMed ID: 31672142
[TBL] [Abstract][Full Text] [Related]
37. Progressive multifocal leukoencephalopathy in myelodysplastic syndrome involving pure red cell aplasia.
Chihara D; Takeoka T; Shirase T; Kishimoto W; Arimoto-Miyamoto K; Tsuji M; Ohno T
Intern Med; 2010; 49(21):2347-52. PubMed ID: 21048373
[TBL] [Abstract][Full Text] [Related]
38. Imbruvica
Murthy V; Weaving S; Paneesha S
Br J Nurs; 2017 May; 26(10):S20-S25. PubMed ID: 28541116
[TBL] [Abstract][Full Text] [Related]
39. Combination of ibrutinib with rituximab, cyclophosphamide, doxorubicin, vincristine, and prednisone (R-CHOP) for treatment-naive patients with CD20-positive B-cell non-Hodgkin lymphoma: a non-randomised, phase 1b study.
Younes A; Thieblemont C; Morschhauser F; Flinn I; Friedberg JW; Amorim S; Hivert B; Westin J; Vermeulen J; Bandyopadhyay N; de Vries R; Balasubramanian S; Hellemans P; Smit JW; Fourneau N; Oki Y
Lancet Oncol; 2014 Aug; 15(9):1019-26. PubMed ID: 25042202
[TBL] [Abstract][Full Text] [Related]
40. Lessons learned from fatal progressive multifocal leukoencephalopathy in a patient with multiple sclerosis treated with natalizumab.
Boster AL; Nicholas JA; Topalli I; Kisanuki YY; Pei W; Morgan-Followell B; Kirsch CF; Racke MK; Pitt D
JAMA Neurol; 2013 Mar; 70(3):398-402. PubMed ID: 23338729
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]